14-day Premium Trial Subscription Try For FreeTry Free
$68.80
-1.54 (-2.19%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Apr 24, 2024 Buy 11 382 Mates Sharon Common Stock
Apr 24, 2024 Buy 8 638 Mates Sharon Common Stock
Apr 24, 2024 Sell 11 382 Mates Sharon Stock Option (right to buy)
Apr 24, 2024 Sell 8 638 Mates Sharon Stock Option (right to buy)
Mar 31, 2024 Buy 79 Van Nostrand Robert L Common Stock
Mar 31, 2024 Buy 260 Riggs Rory B Common Stock
Mar 20, 2024 Buy 20 000 Riggs Rory B Common Stock
Mar 20, 2024 Sell 20 000 Riggs Rory B Stock Option (right to buy)
Mar 11, 2024 Sell 14 541 Mates Sharon Common Stock
Mar 11, 2024 Sell 4 128 Mates Sharon Common Stock
Mar 11, 2024 Sell 1 590 Mates Sharon Common Stock
Mar 11, 2024 Sell 306 Mates Sharon Common Stock
Mar 11, 2024 Sell 4 453 Hineline Lawrence J. Common Stock
Mar 11, 2024 Sell 4 475 Hineline Lawrence J. Common Stock
Mar 11, 2024 Sell 1 100 Hineline Lawrence J. Common Stock
Mar 11, 2024 Sell 29 Hineline Lawrence J. Common Stock
Mar 11, 2024 Sell 64 Hineline Lawrence J. Common Stock
Mar 11, 2024 Sell 6 107 Halstead Michael Common Stock
Mar 11, 2024 Sell 1 238 Halstead Michael Common Stock
Mar 11, 2024 Sell 4 303 Neumann Mark Common Stock
Mar 11, 2024 Sell 1 729 Neumann Mark Common Stock
Mar 11, 2024 Sell 1 313 Neumann Mark Common Stock
Mar 11, 2024 Sell 2 179 Durgam Suresh K. Common Stock
Mar 11, 2024 Sell 872 Durgam Suresh K. Common Stock
Mar 11, 2024 Sell 661 Durgam Suresh K. Common Stock
Mar 10, 2024 Buy 20 565 Mates Sharon Common Stock
Mar 10, 2024 Sell 20 565 Mates Sharon Restricted Stock Units
Mar 10, 2024 Sell 5 582 Hineline Lawrence J. Restricted Stock Units
Mar 10, 2024 Buy 5 582 Hineline Lawrence J. Common Stock
Mar 10, 2024 Sell 4 539 Hineline Lawrence J. Stock Option (right to purchase)
Mar 10, 2024 Buy 4 539 Hineline Lawrence J. Common Stock
Mar 10, 2024 Buy 7 345 Halstead Michael Common Stock
Mar 10, 2024 Sell 7 345 Halstead Michael Restricted Stock Units
Mar 10, 2024 Buy 7 345 Neumann Mark Common Stock
Mar 10, 2024 Sell 7 345 Neumann Mark Restricted Stock Units
Mar 10, 2024 Buy 7 345 Durgam Suresh K. Common Stock
Mar 10, 2024 Sell 7 345 Durgam Suresh K. Restricted Stock Units
Mar 07, 2024 Sell 31 958 Mates Sharon Common Stock
Mar 07, 2024 Sell 8 754 Mates Sharon Common Stock
Mar 07, 2024 Sell 6 514 Hineline Lawrence J. Common Stock
Mar 07, 2024 Sell 6 618 Hineline Lawrence J. Common Stock
Mar 07, 2024 Sell 12 912 Halstead Michael Common Stock
Mar 07, 2024 Sell 220 Halstead Michael Common Stock
Mar 07, 2024 Sell 8 636 Neumann Mark Common Stock
Mar 07, 2024 Sell 4 496 Neumann Mark Common Stock
Mar 07, 2024 Sell 3 728 Durgam Suresh K. Common Stock
Mar 07, 2024 Sell 2 722 Durgam Suresh K. Common Stock
Mar 06, 2024 Buy 13 132 Neumann Mark Common Stock
Mar 06, 2024 Sell 13 132 Neumann Mark Restricted Stock Units
Mar 06, 2024 Buy 40 712 Mates Sharon Common Stock
Mar 06, 2024 Sell 40 712 Mates Sharon Restricted Stock Units
Mar 06, 2024 Sell 13 132 Halstead Michael Restricted Stock Units
Mar 06, 2024 Buy 13 132 Halstead Michael Common Stock
Mar 06, 2024 Sell 13 132 Hineline Lawrence J. Restricted Stock Units
Mar 06, 2024 Buy 13 132 Hineline Lawrence J. Common Stock
Mar 06, 2024 Sell 13 132 Durgam Suresh K. Restricted Stock Units
Mar 06, 2024 Buy 13 132 Durgam Suresh K. Common Stock
Mar 01, 2024 Buy 36 717 Halstead Michael Restricted Stock Units
Mar 01, 2024 Buy 26 227 Hineline Lawrence J. Restricted Stock Units
Mar 01, 2024 Buy 26 227 Neumann Mark Restricted Stock Units
Mar 01, 2024 Buy 26 227 Durgam Suresh K. Restricted Stock Units
Mar 01, 2024 Buy 104 909 Mates Sharon Restricted Stock Units
Feb 27, 2024 Buy 20 000 Van Nostrand Robert L Common Stock
Feb 27, 2024 Sell 9 651 Van Nostrand Robert L Common Stock
Feb 27, 2024 Sell 10 349 Van Nostrand Robert L Common Stock
Feb 27, 2024 Sell 20 000 Van Nostrand Robert L Stock Option (right to buy)
Feb 26, 2024 Sell 300 Halstead Michael Common Stock
Feb 26, 2024 Sell 7 215 Halstead Michael Common Stock
Feb 26, 2024 Sell 392 Halstead Michael Common Stock
Feb 26, 2024 Sell 300 Hineline Lawrence J. Common Stock
Feb 26, 2024 Buy 5 882 Hineline Lawrence J. Common Stock
Feb 26, 2024 Sell 5 282 Hineline Lawrence J. Common Stock
Feb 26, 2024 Sell 6 867 Hineline Lawrence J. Common Stock
Feb 26, 2024 Sell 5 882 Hineline Lawrence J. Stock Option (right to buy)
Feb 26, 2024 Sell 288 Hineline Lawrence J. Common Stock
Feb 26, 2024 Sell 600 Hineline Lawrence J. Common Stock
Feb 26, 2024 Sell 600 Mates Sharon Common Stock
Feb 26, 2024 Sell 9 528 Mates Sharon Common Stock
Feb 26, 2024 Sell 12 462 Mates Sharon Common Stock
Feb 26, 2024 Sell 1 400 Durgam Suresh K. Common Stock
Feb 26, 2024 Sell 1 400 Durgam Suresh K. Common Stock
Feb 26, 2024 Sell 1 312 Durgam Suresh K. Common Stock
Feb 26, 2024 Sell 200 Neumann Mark Common Stock
Feb 26, 2024 Sell 4 059 Neumann Mark Common Stock
Feb 26, 2024 Sell 2 341 Neumann Mark Common Stock
Feb 26, 2024 Sell 1 307 Neumann Mark Common Stock
Feb 26, 2024 Buy 16 757 Marcus Joel S Common Stock
Feb 26, 2024 Sell 8 371 Marcus Joel S Common Stock
Feb 26, 2024 Buy 20 000 Marcus Joel S Common Stock
Feb 26, 2024 Sell 17 658 Marcus Joel S Common Stock
Feb 23, 2024 Buy 7 907 Halstead Michael Common Stock
Feb 23, 2024 Sell 7 907 Halstead Michael Restricted Stock Units
Feb 23, 2024 Buy 7 455 Hineline Lawrence J. Common Stock
Feb 23, 2024 Sell 7 455 Hineline Lawrence J. Restricted Stock Units
Feb 23, 2024 Buy 22 590 Mates Sharon Common Stock
Feb 23, 2024 Sell 22 590 Mates Sharon Restricted Stock Units
Feb 23, 2024 Buy 7 907 Durgam Suresh K. Common Stock
Feb 23, 2024 Sell 7 907 Durgam Suresh K. Restricted Stock Units
Feb 23, 2024 Buy 7 907 Neumann Mark Common Stock
Feb 23, 2024 Sell 7 907 Neumann Mark Restricted Stock Units
JSON CSV
INSIDER POWER
1.792
Last 100 transactions
Buy: 523 032 | Sell: 503 157 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 1.792.

In total, the insiders bought 523 032 and sold 503 157 ITCI shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Intra-Cellular Therapies Inc.

Intra-Cellular Therapies. Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as ... ITCI Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT